ZNF37A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.301600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.700400E-01
Normal-vs-Stage2
2.440000E-01
Normal-vs-Stage3
2.772200E-02
Normal-vs-Stage4
7.976600E-01
Stage1-vs-Stage2
3.048100E-02
Stage1-vs-Stage3
2.582400E-02
Stage1-vs-Stage4
9.976200E-01
Stage2-vs-Stage3
2.635100E-03
Stage2-vs-Stage4
7.410400E-02
Stage3-vs-Stage4
1.025560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.355800E-01
Normal-vs-AfricanAmerican
8.152800E-01
Normal-vs-Asian
9.830000E-02
Caucasian-vs-AfricanAmerican
3.291800E-01
Caucasian-vs-Asian
1.725200E-01
AfricanAmerican-vs-Asian
8.516200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.863200E-01
Normal-vs-Female
4.051600E-01
Male-vs-Female
3.866200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.729600E-01
Normal-vs-Age(41-60Yrs)
5.579000E-01
Normal-vs-Age(61-80Yrs)
2.794200E-01
Normal-vs-Age(81-100Yrs)
5.220200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.796600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.407600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.976000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.806100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.030200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.748400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.530100E-02
Normal-vs-Daily Drinker
6.238400E-02
Normal-vs-Weekly Drinker
4.161000E-01
Normal-vs-Occasional Drinker
4.695200E-01
Normal-vs-Social Drinker
6.885800E-01
Non Drinker-vs-Daily Drinker
8.663800E-01
Non Drinker-vs-Weekly Drinker
6.726000E-02
Non Drinker-vs-Occasional Drinker
1.805180E-01
Non Drinker-vs-Social Drinker
1.221370E-01
Daily Drinker-vs-Weekly Drinker
1.400630E-01
Daily Drinker-vs-Occasional Drinker
2.175600E-01
Daily Drinker-vs-Social Drinker
1.552840E-01
Weekly Drinker-vs-Occasional Drinker
9.161600E-01
Weekly Drinker-vs-Social Drinker
7.378200E-01
Occasional Drinker-vs-Social Drinker
6.731000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.620200E-01
Normal-vs-Grade 2
1.945030E-01
Normal-vs-Grade 3
2.389800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.104000E-01
Grade 1-vs-Grade 3
3.249600E-01
Grade 1-vs-Grade 4
2.620200E-01
Grade 2-vs-Grade 3
3.204200E-01
Grade 2-vs-Grade 4
1.945030E-01
Grade 3-vs-Grade 4
2.389800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.912560E-01
Normal-vs-NonDiabetic
2.114200E-01
Diabetic-vs-NonDiabetic
8.451600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.803500E-02
Normal-vs-NoPancreatitis
2.430000E-01
Pancreatitis-vs-NoPancreatitis
4.446000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.811000E-01
Normal-vs-N1
2.516600E-01
N0-vs-N1
5.355800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.784390E-01
Normal-vs-TP53-NonMutant
9.095400E-01
TP53-Mutant-vs-TP53-NonMutant
1.358850E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
